Legislation introduced to expand Medicare coverage for genetic cancer testing, promoting early detection and prevention.

Quiver AI Summary

U.S. Representatives Debbie Wasserman Schultz, Mariannette Miller-Meeks, Kim Schrier, and Vern Buchanan have announced the re-introduction of bipartisan legislation aimed at expanding access to genetic cancer testing for Medicare beneficiaries. The proposed Reducing Hereditary Cancer Act seeks to remove existing barriers that prevent individuals from accessing important screenings until after a cancer diagnosis.

The legislation is designed to allow coverage for genetic testing based on family history or known hereditary cancer mutations, which proponents argue could lead to earlier detection and treatment, ultimately saving lives and reducing healthcare costs. “It’s nonsensical, wasteful and short-sighted that Medicare doesn’t allow individuals to access this inexpensive screening until they have received a terminal diagnosis,” said Wasserman Schultz.

Advocates, including Lisa Schlager from FORCE and Crystal S. Denlinger from the National Comprehensive Cancer Network, have expressed strong support for the bill, emphasizing that genetic testing can significantly impact cancer management and prevention. The bill aims to inform patients and their families about their genetic risks, promoting proactive healthcare decisions.

Disclaimer: This is an AI-generated summary of a press release. The model used to summarize this release may make mistakes. See the full release here.

🏛️ Receive Alerts on Congress


Sign Up

Debbie Wasserman Schultz Net Worth

Quiver Quantitative estimates that Debbie Wasserman Schultz is worth $516.3K, as of July 28th, 2025. This is the 350th highest net worth in Congress, per our live estimates.

Wasserman Schultz has approximately $97.9K invested in publicly traded assets which Quiver is able to track live.

You can track Debbie Wasserman Schultz’s net worth on Quiver Quantitative’s politician page for Wasserman Schultz.

Debbie Wasserman Schultz Bill Proposals

Here are some bills which have recently been proposed by Debbie Wasserman Schultz:

H.R.4752: To amend title XVIII of the Social Security Act to provide hereditary cancer genetic testing for individuals with a history of a hereditary cancer gene mutation in a blood relative or a personal or ancestral history suspicious for hereditary cancer, and to provide coverage of certain cancer screenings or preventive surgeries that would reduce the risk for individuals with a germline (inherited) mutation associated with a high risk of developing a preventable cancer.H.R.4751: To amend the Virginia Graeme Baker Pool and Spa Safety Act to reauthorize certain programs, and for other purposes.H.R.4542: To prohibit the operation and funding of an immigration detention facility in the Everglades, and for other purposes.H.R.4541: To reauthorize the Young Women’s Breast Health Education and Awareness Requires Learning Young Act of 2009.H.R.2701: Fallen Servicemembers Religious Heritage Restoration ActH.R.2657: Sammy’s Law

You can track bills proposed by Debbie Wasserman Schultz on Quiver Quantitative’s politician page for Wasserman Schultz.

Debbie Wasserman Schultz Fundraising

Debbie Wasserman Schultz recently disclosed $496.5K of fundraising in a Q2 FEC disclosure filed on July 15th, 2025. This was the 156th most from all Q2 reports we have seen this year. 77.0% came from individual donors.

Wasserman Schultz disclosed $241.1K of spending. This was the 214th most from all Q2 reports we have seen from politicians so far this year.

Wasserman Schultz disclosed $1.3M of cash on hand at the end of the filing period. This was the 222nd most from all Q2 reports we have seen this year.

You can see the disclosure here, or track Debbie Wasserman Schultz’s fundraising on Quiver Quantitative.